Home > Insider Trading > Filing (0001181431-14-010791)

Filing Details

Accession Number:: 0001181431-14-010791
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-04 20:01:42
Reporting Period:: 2014-03-01

Filing Date:: 2014-03-04
Accepted Time:: 2014-03-04 20:01:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1179929	Molina Healthcare Inc	MOH	Hospital & Medical Service Plans (6324)	134204626

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1246756	Cpa W Joseph White	300 University Avenue, Suite 100 Sacramento CA 95825	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-03-01	3,657	$37.68	88,957	No	4	F	Direct
Common Stock	Disposition	2014-03-01	7,712	$37.68	81,245	No	4	F	Direct
Common Stock	Acquisiton	2014-03-01	26,540	$37.68	107,785	No	4	A	Direct
Common Stock	Disposition	2014-03-03	2,374	$37.42	105,411	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	F	Direct
No	4	A	Direct
No	4	S	Direct

Footnotes

The shares were applied to the payment of withholding taxes arising in connection with the vesting of 7,007 shares on March 1, 2014, which vested upon the Company achieving three-year EBITDA margin for the three-year period ending December 31, 2013 greater than 2.5%. The achievement of such EBITDA margin was certified by the Compensation Committee on March 1, 2014.
Represents the closing price (and selling price, where applicable) of Issuer's common stock on February 28, 2014.
The shares were applied to the payment of withholding taxes arising in connection with the vesting of 19,586 shares on March 1, 2014.
Grant of restricted stock under the issuer's 2011 Equity Incentive Plan.
The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan.
Represents the actual selling price for all 2,374 shares.
7,007 shares shall vest upon the Company achieving total revenue in any of the 2013, 2014, or 2015 fiscal years equal to or greater than $12 billion; 15,461 shares vest on March 1, 2015; and 6,086 shares vest on March 1, 2016.
The 26,540 newly granted shares vest as follows: (i) 7,962 of such shares vest in one-third increments on each of March 1, 2015, March 1, 2016 and March 1, 2017; (ii) 2,654 of such shares vest upon the Company achieving three-year Total Stockholder Return (TSR) as determined by ISS calculations that is greater than the median TSR achieved by the Company's ISS peer group for the three-year period ending December 31, 2016; (iii) 2,654 of such shares vest on March 1, 2015 contingent upon the Company achieving a one-year TSR as determined by ISS calculations for fiscal year 2014 that is greater than the average TSR achieved by Centene Corporation and WellCare Group for their fiscal year ending December 31, 2014; continued
(iv) 6,635 of such shares vest upon the Company achieving a three-year EBITDA margin percentage for the three-year period ending December 31, 2016 equal to or greater than 4.0%; and (v) 6,635 of such shares vest upon the Company achieving a cumulative earnings per share of at least $8.50 for the three year period ending December 31, 2016. The remainder of the shares are vested.